Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Aging Neurosci ; 16: 1377442, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38765774

RESUMO

Introduction: Parkinson's disease (PD) is the second most common neurodegenerative disease and affects millions of people. Accurate diagnosis and subsequent treatment in the early stages can slow down disease progression. However, making an accurate diagnosis of PD at an early stage is challenging. Previous studies have revealed that even for movement disorder specialists, it was difficult to differentiate patients with PD from healthy individuals until the average modified Hoehn-Yahr staging (mH&Y) reached 1.8. Recent researches have shown that dysarthria provides good indicators for computer-assisted diagnosis of patients with PD. However, few studies have focused on diagnosing patients with PD in the early stages, specifically those with mH&Y ≤ 1.5. Method: We used a machine learning algorithm to analyze voice features and developed diagnostic models for differentiating between healthy controls (HCs) and patients with PD, and for differentiating between HCs and patients with mild PD (mH&Y ≤ 1.5). The models were independently validated using separate datasets. Results: Our results demonstrate that, a remarkable diagnostic performance of the model in identifying patients with mild PD (mH&Y ≤ 1.5) and HCs, with area under the ROC curve 0.93 (95% CI: 0.851.00), accuracy 0.85, sensitivity 0.95, and specificity 0.75. Conclusion: The results of our study are helpful for screening PD in the early stages in the community and primary medical institutions where there is a lack of movement disorder specialists and special equipment.

2.
J Parkinsons Dis ; 14(4): 777-795, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38640168

RESUMO

Background: Multiple system atrophy (MSA) is a disease with diverse symptoms and the commonly used classifications, MSA-P and MSA-C, do not cover all the different symptoms seen in MSA patients. Additionally, these classifications do not provide information about how the disease progresses over time or the expected outcome for patients. Objective: To explore clinical subtypes of MSA with a natural disease course through a data-driven approach to assist in the diagnosis and treatment of MSA. Methods: We followed 122 cases of MSA collected from 3 hospitals for 3 years. Demographic characteristics, age of onset, clinical signs, scale assessment scores, and auxiliary examination were collected. Age at onset; time from onset to assisted ambulation; and UMSARS I, II, and IV, COMPASS-31, ICARS, and UPDRS III scores were selected as clustering elements. K-means, partitioning around medoids, and self-organizing maps were used to analyze the clusters. Results: The results of all three clustering methods supported the classification of three MSA subtypes: The aggressive progression subtype (MSA-AP), characterized by mid-to-late onset, rapid progression and severe clinical symptoms; the typical subtype (MSA-T), characterized by mid-to-late onset, moderate progression and moderate severity of clinical symptoms; and the early-onset slow progression subtype (MSA-ESP), characterized by early-to-mid onset, slow progression and mild clinical symptoms. Conclusions: We divided MSA into three subtypes and summarized the characteristics of each subtype. According to the clustering results, MSA patients were divided into three completely different types according to the severity of symptoms, the speed of disease progression, and the age of onset.


Assuntos
Progressão da Doença , Atrofia de Múltiplos Sistemas , Humanos , Atrofia de Múltiplos Sistemas/classificação , Atrofia de Múltiplos Sistemas/diagnóstico , Masculino , Feminino , Pessoa de Meia-Idade , Idoso , Análise por Conglomerados , Idade de Início , Índice de Gravidade de Doença
4.
CNS Neurosci Ther ; 30(3): e14575, 2024 03.
Artigo em Inglês | MEDLINE | ID: mdl-38467597

RESUMO

BACKGROUND: Levodopa could induce orthostatic hypotension (OH) in Parkinson's disease (PD) patients. Accurate prediction of acute OH post levodopa (AOHPL) is important for rational drug use in PD patients. Here, we develop and validate a prediction model of AOHPL to facilitate physicians in identifying patients at higher probability of developing AOHPL. METHODS: The study involved 497 PD inpatients who underwent a levodopa challenge test (LCT) and the supine-to-standing test (STS) four times during LCT. Patients were divided into two groups based on whether OH occurred during levodopa effectiveness (AOHPL) or not (non-AOHPL). The dataset was randomly split into training (80%) and independent test data (20%). Several models were trained and compared for discrimination between AOHPL and non-AOHPL. Final model was evaluated on independent test data. Shapley additive explanations (SHAP) values were employed to reveal how variables explain specific predictions for given observations in the independent test data. RESULTS: We included 180 PD patients without AOHPL and 194 PD patients with AOHPL to develop and validate predictive models. Random Forest was selected as our final model as its leave-one-out cross validation performance [AUC_ROC 0.776, accuracy 73.6%, sensitivity 71.6%, specificity 75.7%] outperformed other models. The most crucial features in this predictive model were the maximal SBP drop and DBP drop of STS before medication (ΔSBP/ΔDBP). We achieved a prediction accuracy of 72% on independent test data. ΔSBP, ΔDBP, and standing mean artery pressure were the top three variables that contributed most to the predictions across all individual observations in the independent test data. CONCLUSIONS: The validated classifier could serve as a valuable tool for clinicians, offering the probability of a patient developing AOHPL at an early stage. This supports clinical decision-making, potentially enhancing the quality of life for PD patients.


Assuntos
Hipotensão Ortostática , Doença de Parkinson , Humanos , Levodopa/efeitos adversos , Hipotensão Ortostática/induzido quimicamente , Hipotensão Ortostática/diagnóstico , Qualidade de Vida , Pressão Sanguínea , Doença de Parkinson/tratamento farmacológico
6.
J Neurol ; 270(4): 2283-2301, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-36725698

RESUMO

BACKGROUND: Differentiating early-stage Parkinson's disease (PD) from essential tremor (ET) is challenging since they have some overlapping clinical features. Since early-stage PD may present with slight gait impairment and ET generally does not, gait analysis could be used to differentiate PD from ET using machine learning. OBJECTIVE: To differentiate early-stage PD from ET via machine learning using gait and postural transition parameters calculated using the raw kinematic signal captured from inertial measurement unit (IMU) sensors. METHODS: Gait and postural transition parameters were collected from 84 early-stage PD and 80 ET subjects during the Time Up and Go (TUG) test. We randomly split our data into training and test data. Within the training data, we separated the TUG test into four components: standing, straight walk, turning, and sitting to build weighted average ensemble classification models. The four components' weight indices were trained using logistic regression. Several ensemble models' leave-one-out cross-validation (LOOCV) performances were compared. Independent test data were used to evaluate the model with the best LOOCV performance. RESULTS: The best weighted average ensemble classification model LOOCV results included an accuracy of 84%, Kappa of 0.68, sensitivity of 85.9%, specificity of 82.1%, and AUC of 0.912. Thirty-three gait and postural transition parameters, such as Arm-Symbolic Symmetry Index and 180° Turn-Max Angular Velocity, were included in Feature Group III. The independent test data achieved a 75.8% accuracy. CONCLUSIONS: Our findings suggest that gait and postural transition parameters obtained from wearable sensors combined with machine learning had the potential to distinguish between early-stage PD and ET.


Assuntos
Tremor Essencial , Doença de Parkinson , Dispositivos Eletrônicos Vestíveis , Humanos , Tremor Essencial/diagnóstico , Marcha , Análise da Marcha , Doença de Parkinson/diagnóstico , Equilíbrio Postural
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...